Matches in Nanopublications for { ?s ?p "DDI between Nilotinib and Etravirine - Nilotinib, when used concomitantly with etravirine (a strong CYP3A4 inducer), may experience a decrease in serum concentration. It is recommended to avoid concurrent therapy. [drugbank_resource:DB04868_DB06414]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB04868_DB06414 label "DDI between Nilotinib and Etravirine - Nilotinib, when used concomitantly with etravirine (a strong CYP3A4 inducer), may experience a decrease in serum concentration. It is recommended to avoid concurrent therapy. [drugbank_resource:DB04868_DB06414]" assertion.